Placenta Extract: Raw Material Traceability and Origin Transparency

Abstract

Placenta extract is one of the more established ingredients in Japan's health food market. The verifiable quality of these products depends directly on the sourcing of raw materials, the extraction and hydrolysis processes employed, and the integrity of the supply chain. This paper systematically examines the current state of the industry and applicable regulatory requirements across four dimensions: animal species and geographic origin of raw materials, extraction and hydrolysis technology, Japan's domestic supply chain management framework, and third-party testing and labeling transparency. It is intended as a foundational reference for consumers, researchers, and industry professionals. No efficacy or medical claims are made anywhere in this document; all discussion is confined to objective matters of raw material traceability and information transparency.

---

1. Classification of Placenta Extract Raw Materials

1.1 Animal Species

In the health food sector, placenta extract raw materials are regulated primarily according to the following animal-derived categories:

Porcine Placenta

Porcine placenta is the most widely used placenta extract raw material in the health food market. Its anatomical similarities to human tissue made it the preferred subject of early research and, today, it underpins the most mature and developed supply chain in the category. Porcine placentas used in food-grade processing in Japan are collected primarily from quarantine-cleared slaughterhouses and must comply with the Food Sanitation Act (*Shokuhin Eiseiho*).

Equine Placenta

Equine placenta is the second most prevalent category in Japan's placenta extract health food industry. Because the equine placenta is expelled naturally after foaling and must be collected within an extremely narrow window — typically within a few hours of birth — the logistics requirements placed on source farms are considerable. The principal sources of equine placenta raw material include Japan's Hokkaido region, Australia, and New Zealand.

Special Status of Human Placenta Extract

In Japan, human placenta extract (*hito purasenta ekisu*) is regulated as a pharmaceutical product; representative products require a prescription and do not circulate within the general health food regulatory framework. All subsequent discussion in this paper of "placenta extract health foods" refers exclusively to the animal-derived materials described above and does not encompass any human-derived preparations.

1.2 Other Animal Sources

Smaller-volume raw materials derived from deer and sheep are also present in the market, sourced primarily through imports, and together represent a limited overall market share. Some products are marketed as offering "rare-source" placenta extract; consumers and researchers should pay particular attention to the availability of origin documentation when evaluating such products.

---

2. Principal Origins and Origin Transparency

2.1 Domestic Origins

Domestic porcine placenta raw material is concentrated primarily in regions with well-developed livestock industries, including Hokkaido, Kagoshima, and Miyazaki. The key advantage of domestically sourced raw material is that it falls under Food Sanitation Act jurisdiction throughout the supply chain: slaughter operations must be inspected by inspectors authorized by the Ministry of Agriculture, Forestry and Fisheries (MAFF), and raw materials are traceable to specific slaughterhouse lots.

For equine placenta, the Hidaka region of Hokkaido is one of Japan's most important horse-breeding areas. Some manufacturers have entered into direct procurement agreements with local farms, and lot number records can in principle be used to trace raw materials back to a specific farm.

2.2 Import Sources

Australia and New Zealand

Both countries are significant sources of equine placenta raw material for Japan, owing to their rigorous animal health management systems and large-scale pastoral industries. Australia's Department of Agriculture, Fisheries and Forestry (DAFF) enforces a strict health certificate regime for exported animal products; New Zealand's Ministry for Primary Industries (MPI) similarly requires official sanitary certificates to accompany exported animal-derived materials. These certificates are mandatory documents for importers completing customs declarations and Ministry of Health, Labour and Welfare (MHLW) import quarantine procedures.

Other Import Sources

Some raw materials originate from Eastern Europe or South America. Because veterinary inspection systems and traceability standards in these regions vary considerably, independently verifying the traceability of such materials can be more difficult. Consumers and researchers should focus on whether importers retain complete veterinary sanitary certificates and quarantine clearance records.

2.3 Current Industry Practice in Origin Labeling

Japan's Health Promotion Act (*Kenko Zoshin-ho*) and the Act Against Unjustifiable Premiums and Misleading Representations prohibit false or misleading country-of-origin statements on health food labels. However, there is currently no uniform mandatory standard governing how "origin" must be indicated on health food labels. Some products list only the country of manufacture (Japan) without disclosing the country of origin of the raw material — a gap that leaves consumers with an incomplete information picture.

Consumers or researchers seeking to verify raw material origin may consult the following sources: the manufacturer's website, typically under a section titled "Full Ingredient and Raw Material Origin Information" (*zen seibun · genzairyo sanchi joho*), or by submitting a written request to the manufacturer for raw material origin information, consistent with the disclosure spirit of the Food Labeling Act (*Shokuhin Hyoji-ho*).

---

3. Extraction and Hydrolysis Processes

3.1 The Central Role of Hydrolysis

Whether the source material is porcine or equine, the core processing step for food-grade placenta extract products is hydrolysis (*kasuibunkai*). The purpose of hydrolysis is to break down the high-molecular-weight proteins in placental tissue into lower-molecular-weight peptides and amino acids, rendering the material suitable for food processing applications.

The industry employs several principal hydrolysis pathways:

Enzymatic Hydrolysis

Food-grade proteases cleave placental tissue under temperature-controlled conditions. The reaction conditions are relatively mild, which is favorable for retaining heat-sensitive low-molecular-weight components. Key quality control parameters in enzymatic hydrolysis include: protease type and purity, substrate concentration, reaction temperature and pH, hydrolysis duration, and termination conditions.

Acid Hydrolysis

Food-grade hydrochloric acid is used as the hydrolyzing agent under heated conditions. Acid hydrolysis offers higher efficiency but results in lower retention of certain amino acids — notably tryptophan — and requires rigorous neutralization and decolorization steps before the hydrolysate can proceed to downstream processing.

Alkaline Hydrolysis

This method is less common and is used primarily in the pre-treatment stage for certain raw materials.

3.2 Purification and Concentration

Following hydrolysis, the crude hydrolysate is subjected to filtration, centrifugation, and ultrafiltration to remove high-molecular-weight residues and reduce microbial contamination risk. The purified hydrolysate is then converted to powder form via spray drying or freeze drying (lyophilization).

Typical quality control specifications for the finished powder include: moisture content, total nitrogen (used as a surrogate indicator of the degree of protein hydrolysis), heavy metal concentrations (lead, arsenic, cadmium, mercury), pesticide and veterinary drug residues, microbial limits (total aerobic count, coliforms), and allergen labeling compliance.

3.3 Distinguishing Natural-Source from Synthetic Products

The vast majority of placenta extract ingredients in commercially available health food products are natural extracts derived from animal placentas, not synthetic chemical compounds. Some products indicate "naturally derived" (*tennen yurai*) on their labels to make this distinction explicit. To verify the nature of the ingredient, consumers may check the ingredient name field on the label: designations such as *buta purasenta ekisu-matsu* (porcine placenta extract powder) or *uma purasenta ekisu* (equine placenta extract) indicate natural extracts, whereas terms such as *purasenta-yo peptido* (placenta-like peptides) indicate a chemically derived substance of a different character.

---

4. Japan's Supply Chain Management Framework and GMP Certification

4.1 Food Sanitation Act and Raw Material Controls

The collection and primary processing of placenta extract raw materials must be carried out within the framework of Japan's Food Sanitation Act. Collection facilities for animal-derived materials — such as slaughterhouses — must hold prefectural operating licenses and are subject to regular sanitary inspections. Imported raw materials must pass import notification review at quarantine stations (*kensekisho*) under MHLW jurisdiction; non-conforming lots are either destroyed or returned to the country of origin.

4.2 The GMP Certification System

In Japan's health food industry, the GMP Compliance Certification (*GMP Tekigo Nintei*) administered by the Japan Health and Nutrition Food Association (JHNFA) (*Koueki Zaidan Hojin Nihon Kenko Eiyo Shokuhin Kyokai*) is an important third-party certification for assessing a manufacturer's quality management capability. Certification requires manufacturers to establish documented quality control procedures covering raw material receipt, processing, testing, packaging, storage, and dispatch at each stage of production, and to undergo periodic on-site audits.

JHNFA GMP-certified facilities must maintain complete batch production records (*batchi kiroku*) that, in principle, enable full-chain traceability from finished product lots back to raw material suppliers and raw material lots. Consumers can search the JHNFA's official website for the list of certified operators to verify a manufacturer's certification status and certification number.

4.3 Practical Traceability Levels

In practice, the traceability of placenta extract products typically spans the following levels:

Most manufacturers are currently able to provide traceability documentation for the first two to three levels. Disclosure of the fourth level — specific animal origin — to external parties remains a voluntary industry practice; no regulatory requirement currently mandates it.

---

5. Third-Party Testing and Information Transparency

5.1 The Role of Third-Party Testing

Independent third-party laboratory test reports (*daisan-sha kikan shiken seisekisho*) are a critical pillar of product verifiability. For placenta extract products, the testing categories of substantive significance typically include:

• Heavy metal testing: Concentrations of lead (Pb), arsenic (As), cadmium (Cd), and mercury (Hg) must comply with limits established under the Food Sanitation Act.
• Microbiological testing: Total aerobic count, coliforms, *Staphylococcus aureus*, and other relevant indicators.
• Pesticide and veterinary drug residue testing: Particularly important for imported raw materials; a residue test report (*zanryu noyaku · dobutsuyo iyakuhin kensa*) should be available.
• Protein/peptide content: As a quantitative specification descriptor for the raw material, total protein content is typically measured by the Kjeldahl method or Bradford assay.

5.2 Dimensions for Assessing Label Transparency

When purchasing or evaluating a placenta extract product, the following label elements provide actionable criteria for assessing information transparency:

• 1. Ingredient name: Does the label clearly identify the animal species from which the raw material is derived (porcine / equine / other)?
• 2. Country of raw material origin: Does the label disclose the country of origin of the raw material (distinct from the country of manufacture of the finished product)?
• 3. Quantity declared: Is the amount of placenta extract (*ekisu*) per daily serving stated in milligrams, or expressed as a dried-placenta-equivalent weight?
• 4. Manufacturer information: Does the label provide contact details for the domestic manufacturer (*seizosha*) or seller (*hanbaisha*)?
• 5. GMP certification status: Does the manufacturing facility hold GMP certification from JHNFA or an equivalent body, and is the certification number verifiable?

---

6. Actionable Guidance for Consumers

The following practical recommendations are provided for consumers purchasing or evaluating placenta extract health food products. All points are grounded in verifiable information; no efficacy judgments are made.

1. Verify GMP Certification Status

Visit the JHNFA's official website and search the "List of GMP-Certified Health Supplement Manufacturers" (*Kenko Hojo Shokuhin GMP Nintei Jigyo-sha Ichiran*) by manufacturer name or certification number to confirm that the manufacturing facility's certification is current and valid.

2. Confirm Animal Species and Raw Material Origin

The ingredient name field on the product label should enable identification of the animal species (porcine/*buta* or equine/*uma*). If the label does not disclose the country of origin of the raw material, consumers may submit a written inquiry to the manufacturer's customer service. Consistent with the disclosure spirit of the Food Labeling Act, consumers have a reasonable basis to request this information.

3. Request Third-Party Test Reports

Reputable manufacturers should be able to provide a current-lot third-party Certificate of Analysis (COA) covering, at minimum, heavy metals and microbiological parameters. If a manufacturer is unable to supply any third-party test documentation, caution is warranted.

4. Distinguish "Extract Quantity" from "Placenta-Equivalent Weight"

Some products declare the amount of placenta extract (*ekisu*) in milligrams; others state the equivalent expressed as dried placenta weight. The numerical difference between the two is substantial — the dried-placenta-equivalent figure is typically approximately ten times higher or more than the extract figure. When comparing products across brands, always normalize to a consistent basis rather than comparing absolute numbers directly.

5. Check Allergen Labeling

Consumers with a known allergy to pork or horse meat should confirm whether the product's allergen information field explicitly identifies the relevant animal source. Under Japan's Food Labeling Act, pork is a recommended (but not mandatory) allergen label item; horse meat is currently included on neither the mandatory nor the recommended list, meaning consumers must proactively confirm this directly with the manufacturer.

6. Retain Packaging and Lot Information

Consumers are advised to keep product packaging until the product is fully consumed. The lot number (*rotto bango*) is the sole identifier needed to initiate a traceability inquiry in the event of a quality concern.

---

Conclusion

Placenta extract is a mature category within Japan's health food market, and its raw material sourcing, extraction processes, and supply chain operations have developed a degree of established industry practice. However, there remains meaningful room for improvement across the industry with respect to the proactive external disclosure of origin information. GMP certification, third-party test reports, and complete batch traceability records represent the three core reference criteria currently available to consumers and researchers for assessing verifiable product quality.

As enforcement of the Food Labeling Act continues to strengthen and consumer information literacy rises, proactive supply chain transparency disclosure is increasingly becoming a competitive differentiator for leading manufacturers. For consumers seeking reliable information, prioritizing products manufactured at JHNFA GMP-certified facilities, supported by available third-party test reports, and labeled with clear disclosure of the animal species and geographic origin of the raw material represents the most actionable verification pathway within the current regulatory and information landscape.

All discussion in this paper is confined to objective and verifiable matters of raw material traceability, process description, and information transparency. Placenta extract products are foods, not pharmaceuticals. Consumers should consult a licensed medical or nutrition professional before making any health-related decisions.